State Street Corp Veracyte, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Veracyte, Inc. stock. As of the latest transaction made, State Street Corp holds 2,916,515 shares of VCYT stock, worth $114 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,916,515

Previous 2,908,595 0.27%

Holding current value

$114 Million

Previous $63 Million 57.47%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$21.0 - $35.25 $166,320 - $279,180	7,920 Added 0.27%	2,916,515 $99.2 Million
Q2 2024 Aug 14, 2024	SELL	$18.86 - $23.55 $26.8 Million - $33.4 Million	-1,418,432 Reduced 32.78%	2,908,595 $63 Million
Q1 2024 May 15, 2024	BUY	$21.0 - $29.1 $25.6 Million - $35.5 Million	1,218,388 Added 39.19%	4,327,027 $95.9 Million
Q4 2023 Feb 14, 2024	SELL	$19.72 - $28.68 $2.81 Million - $4.09 Million	-142,653 Reduced 4.39%	3,108,639 $85.5 Million
Q3 2023 Nov 14, 2023	SELL	$22.33 - $29.92 $8.07 Million - $10.8 Million	-361,336 Reduced 10.0%	3,251,292 $72.6 Million
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $11.7 Million - $15.1 Million	-559,291 Reduced 13.41%	3,612,628 $92 Million
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $259,061 - $351,079	12,588 Added 0.3%	4,171,919 $93 Million
Q4 2022 Feb 14, 2023	SELL	$15.31 - $29.94 $16.3 Million - $31.9 Million	-1,064,565 Reduced 20.38%	4,159,331 $98.7 Million
Q3 2022 Nov 15, 2022	BUY	$16.58 - $27.9 $1.32 Million - $2.22 Million	79,565 Added 1.55%	5,223,896 $86.7 Million
Q2 2022 Aug 15, 2022	BUY	$15.45 - $29.52 $18.5 Million - $35.4 Million	1,198,461 Added 30.37%	5,144,331 $102 Million
Q1 2022 May 16, 2022	BUY	$21.94 - $42.51 $27.1 Million - $52.5 Million	1,234,244 Added 45.52%	3,945,870 $109 Million
Q4 2021 Feb 14, 2022	BUY	$36.09 - $53.79 $9.94 Million - $14.8 Million	275,487 Added 11.31%	2,711,626 $112 Million
Q3 2021 Nov 15, 2021	SELL	$35.62 - $52.97 $4.22 Million - $6.28 Million	-118,516 Reduced 4.64%	2,436,139 $113 Million
Q2 2021 Aug 16, 2021	BUY	$32.94 - $56.62 $12.8 Million - $22.1 Million	389,722 Added 18.0%	2,554,655 $102 Million
Q1 2021 May 17, 2021	BUY	$44.47 - $81.38 $121,047 - $221,516	2,722 Added 0.13%	2,164,933 $116 Million
Q4 2020 Feb 16, 2021	SELL	$32.49 - $61.88 $714,487 - $1.36 Million	-21,991 Reduced 1.01%	2,162,211 $106 Million
Q3 2020 Nov 10, 2020	SELL	$26.73 - $35.67 $953,779 - $1.27 Million	-35,682 Reduced 1.61%	2,184,202 $71 Million
Q2 2020 Aug 14, 2020	BUY	$19.49 - $28.11 $4.28 Million - $6.18 Million	219,774 Added 10.99%	2,219,884 $57.5 Million
Q1 2020 May 11, 2020	BUY	$16.13 - $30.17 $32.3 Million - $60.3 Million	2,000,110 New	2,000,110 $48.6 Million

Others Institutions Holding VCYT

# of Institutions

308

Shares Held

81.8M

Call Options Held

134K

Put Options Held

13.3K

View Full List

About VERACYTE, INC.

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.81B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

More about VCYT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Veracyte, Inc. Transaction History